Through its ability to significantly reduce TSLP and periostin levels in HaCaT keratinocytes, as depicted in Fig. 1, I3C presents a promising approach for targeting inflammatory pathways implicated in AD. This evidence concerns the gene TSLP and Alzheimer disease.